21-43060480-C-T

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PP2PP3_Strong

The NM_000071.3(CBS):​c.1106G>A​(p.Arg369His) variant causes a missense change. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R369C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000024 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CBS
NM_000071.3 missense

Scores

8
9
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 4.70

Publications

10 publications found
Variant links:
Genes affected
CBS (HGNC:1550): (cystathionine beta-synthase) The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016]
CBS Gene-Disease associations (from GenCC):
  • classic homocystinuria
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, PanelApp Australia, ClinGen, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 8 uncertain in NM_000071.3
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 107 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Gene score misZ: 0.8318 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to classic homocystinuria.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.99

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CBSNM_000071.3 linkc.1106G>A p.Arg369His missense_variant Exon 12 of 17 ENST00000398165.8 NP_000062.1 P35520-1Q9NTF0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CBSENST00000398165.8 linkc.1106G>A p.Arg369His missense_variant Exon 12 of 17 1 NM_000071.3 ENSP00000381231.4 P35520-1

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
68
Hom.:
0
Cov.:
0
Gnomad AFR
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad NFE
AF:
0.00
GnomAD2 exomes
AF:
0.0000121
AC:
3
AN:
247156
AF XY:
0.0000223
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000892
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000240
AC:
1
AN:
41672
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
22338
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
2376
American (AMR)
AF:
0.00
AC:
0
AN:
3666
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
930
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
6850
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1188
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
164
European-Non Finnish (NFE)
AF:
0.0000462
AC:
1
AN:
21654
Other (OTH)
AF:
0.00
AC:
0
AN:
2150
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
68
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
38
African (AFR)
AF:
0.00
AC:
0
AN:
20
American (AMR)
AF:
0.00
AC:
0
AN:
8
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AF:
0.00
AC:
0
AN:
8
South Asian (SAS)
AF:
0.00
AC:
0
AN:
14
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
16
Other (OTH)
AC:
0
AN:
0
Alfa
AF:
0.000208
Hom.:
0
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 04, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CBS c.1106G>A (p.Arg369His) results in a non-conservative amino acid change located in the Tryptophan synthase beta chain-like, PALP domain (IPR001926) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 247156 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1106G>A has been reported in the literature in an individual affected with Homocystinuria (Kraus_1994). These report(s) do not provide unequivocal conclusions about association of the variant with Homocystinuria. At least one publication reports experimental evidence evaluating an impact on protein function. These results showed no damaging effect of this variant (Mayfield_2012). The following publications have been ascertained in the context of this evaluation (PMID: 7967489, 22267502). ClinVar contains an entry for this variant (Variation ID: 578836). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Classic homocystinuria Uncertain:1
Sep 02, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED Uncertain:1
Sep 02, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine with histidine at codon 369 of the CBS protein (p.Arg369His). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and histidine. This variant is present in population databases (rs11700812, ExAC 0.01%). This missense change has been observed in individual(s) with CBS deficiency (PMID: 7967489). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change does not substantially affect CBS function (PMID: 22267502). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Oct 23, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The CBS c.1106G>A; p.Arg369His variant (rs11700812), is reported in the literature in several individuals affected with homocystinuria, although the clinical significant of this variant was not demonstrated (CBS mutation database and references therein). This variant is found on only four chromosomes (4/278538 alleles) in the Genome Aggregation Database. The arginine at codon 369 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.907). Additionally, another amino acid substitution at this codon (p.Arg369Cys) has been reported in individuals with homocystinuria, although its clinical significance was considered uncertain (Kim 1997). Further, both the p.Arg369His and p.Arg369Cys variants exhibit activity comparable to wildtype CBS in yeast complementation assays (Kim 1997, Mayfield 2012). Due to limited and conflicting information, the clinical significance of the p.Arg369His variant is uncertain at this time. References: CBS mutation database: http://cbs.lf1.cuni.cz/mutations.php Kim et al. Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria. Hum Mol Genet. 1997; 6(13): 2213-2221. Mayfield et al. Surrogate genetics and metabolic profiling for characterization of human disease alleles. Genetics. 2012 Apr;190(4):1309-23. PMID: 22267502. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Pathogenic
0.51
D
BayesDel_noAF
Pathogenic
0.50
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.97
D;D;D;D
Eigen
Uncertain
0.68
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.97
.;.;.;D
M_CAP
Pathogenic
0.77
D
MetaRNN
Pathogenic
0.99
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.6
M;M;M;M
PhyloP100
4.7
PrimateAI
Uncertain
0.54
T
PROVEAN
Uncertain
-3.7
D;D;D;D
REVEL
Pathogenic
0.91
Sift
Uncertain
0.013
D;D;D;D
Sift4G
Uncertain
0.016
D;D;D;D
Polyphen
1.0
D;D;D;D
Vest4
0.75
MutPred
0.91
Gain of catalytic residue at C370 (P = 0.0669);Gain of catalytic residue at C370 (P = 0.0669);Gain of catalytic residue at C370 (P = 0.0669);Gain of catalytic residue at C370 (P = 0.0669);
MVP
0.94
MPC
1.2
ClinPred
0.89
D
GERP RS
4.9
PromoterAI
0.0042
Neutral
Varity_R
0.87
gMVP
0.80
Mutation Taster
=0/100
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11700812; hg19: chr21-44480590; API